Cargando…
Targeting the Ubiquitylation and ISGylation Machinery for the Treatment of COVID-19
Ubiquitylation and ISGylation are protein post-translational modifications (PTMs) and two of the main events involved in the activation of pattern recognition receptor (PRRs) signals allowing the host defense response to viruses. As with similar viruses, SARS-CoV-2, the virus causing COVID-19, hijac...
Autores principales: | Vere, George, Alam, Md Rashadul, Farrar, Sam, Kealy, Rachel, Kessler, Benedikt M., O’Brien, Darragh P., Pinto-Fernández, Adán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869442/ https://www.ncbi.nlm.nih.gov/pubmed/35204803 http://dx.doi.org/10.3390/biom12020300 |
Ejemplares similares
-
Ubiquitomics: An Overview and Future
por: Vere, George, et al.
Publicado: (2020) -
Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity
por: Pinto-Fernandez, Adan, et al.
Publicado: (2020) -
Human Platelet Protein Ubiquitylation and Changes following GPVI Activation
por: Unsworth, Amanda J., et al.
Publicado: (2019) -
ISG15 and ISGylation in Human Diseases
por: Mirzalieva, Oygul, et al.
Publicado: (2022) -
DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets
por: Pinto-Fernandez, Adan, et al.
Publicado: (2016)